Co-amoxiclav, or AMCLAV, is recommended for the short-term treatment of bacterial infections, especially those of the upper respiratory tract (ENT), which include tonsillitis, sinusitis, and otitis media. Infections affecting the lower respiratory tract, such as acute flare-ups of long-term bronchitis, lobar pneumonia, and bronchopneumonia.